233 related articles for article (PubMed ID: 19211715)
1. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.
Okamura DM; Pennathur S; Pasichnyk K; López-Guisa JM; Collins S; Febbraio M; Heinecke J; Eddy AA
J Am Soc Nephrol; 2009 Mar; 20(3):495-505. PubMed ID: 19211715
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.
Okamura DM; López-Guisa JM; Koelsch K; Collins S; Eddy AA
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F575-85. PubMed ID: 17537985
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.
Souza AC; Bocharov AV; Baranova IN; Vishnyakova TG; Huang YG; Wilkins KJ; Hu X; Street JM; Alvarez-Prats A; Mullick AE; Patterson AP; Remaley AT; Eggerman TL; Yuen PS; Star RA
Kidney Int; 2016 Apr; 89(4):809-22. PubMed ID: 26994575
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
Yang P; Xiao Y; Luo X; Zhao Y; Zhao L; Wang Y; Wu T; Wei L; Chen Y
J Lipid Res; 2017 Jul; 58(7):1417-1427. PubMed ID: 28536108
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.
Janabi M; Yamashita S; Hirano K; Sakai N; Hiraoka H; Matsumoto K; Zhang Z; Nozaki S; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1953-60. PubMed ID: 10938017
[TBL] [Abstract][Full Text] [Related]
6. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
Han J; Hajjar DP; Febbraio M; Nicholson AC
J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
[TBL] [Abstract][Full Text] [Related]
7. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses.
Chen Y; Yang M; Huang W; Chen W; Zhao Y; Schulte ML; Volberding P; Gerbec Z; Zimmermann MT; Zeighami A; Demos W; Zhang J; Knaack DA; Smith BC; Cui W; Malarkannan S; Sodhi K; Shapiro JI; Xie Z; Sahoo D; Silverstein RL
Circ Res; 2019 Dec; 125(12):1087-1102. PubMed ID: 31625810
[TBL] [Abstract][Full Text] [Related]
9. Cardiotonic Steroids Stimulate Macrophage Inflammatory Responses Through a Pathway Involving CD36, TLR4, and Na/K-ATPase.
Chen Y; Huang W; Yang M; Xin G; Cui W; Xie Z; Silverstein RL
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1462-1469. PubMed ID: 28619997
[TBL] [Abstract][Full Text] [Related]
10. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
[TBL] [Abstract][Full Text] [Related]
11. Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades.
Eddy AA
Kidney Int; 1998 May; 53(5):1182-9. PubMed ID: 9573532
[TBL] [Abstract][Full Text] [Related]
12. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.
Kuchibhotla S; Vanegas D; Kennedy DJ; Guy E; Nimako G; Morton RE; Febbraio M
Cardiovasc Res; 2008 Apr; 78(1):185-96. PubMed ID: 18065445
[TBL] [Abstract][Full Text] [Related]
13. CD36 in chronic kidney disease: novel insights and therapeutic opportunities.
Yang X; Okamura DM; Lu X; Chen Y; Moorhead J; Varghese Z; Ruan XZ
Nat Rev Nephrol; 2017 Dec; 13(12):769-781. PubMed ID: 28919632
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36.
Silverstein RL
Cleve Clin J Med; 2009 Apr; 76 Suppl 2(Suppl 2):S27-30. PubMed ID: 19376978
[TBL] [Abstract][Full Text] [Related]
15. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
Ding W; Wang B; Zhang M; Gu Y
Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424
[TBL] [Abstract][Full Text] [Related]
16. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
[TBL] [Abstract][Full Text] [Related]
17. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
[TBL] [Abstract][Full Text] [Related]
18. The role of CD36 receptor in the pathogenesis of atherosclerosis.
Choromańska B; Myśliwiec P; Choromańska K; Dadan J; Chabowski A
Adv Clin Exp Med; 2017 Jul; 26(4):717-722. PubMed ID: 28691408
[TBL] [Abstract][Full Text] [Related]
19. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36.
Han J; Hajjar DP; Tauras JM; Nicholson AC
J Lipid Res; 1999 May; 40(5):830-8. PubMed ID: 10224152
[TBL] [Abstract][Full Text] [Related]
20. Pattern recognition scavenger receptors, SR-A and CD36, have an additive role in the development of colitis in mice.
Oz HS; Zhong J; de Villiers WJ
Dig Dis Sci; 2009 Dec; 54(12):2561-7. PubMed ID: 19117124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
